𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients

✍ Scribed by P. Christensen; H. Y. Thomsen; O. L. Pedersen; P. Thayssen; H. Oxhøj; P. Kragh-Sørensen; L. F. Gram

Publisher
Springer
Year
1985
Tongue
English
Weight
398 KB
Volume
87
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis

Thirteen elderly depressed patients (age 60-82 years) were treated for 5 weeks with a fixed dose of amitriptyline 100 mg (sustained release preparation). In all patients the sum of concentrations of amitriptyline and nortriptyline exceeded 130 gg/1, which is the recommended plasma level. Cardiovascular side effects were recorded by monitoring heart rate, blood pressure, standard ECG and systolic time intervals. During treatment, a transient increase in the supine heart rate was observed without significant changes in the supine blood pressure. The orthostatic drop in blood pressure was markedly increased during treatment without a compensatory increase in heart rate, and these changes remained significant during the whole investigational period. PQ and QRS were significantly increased during treatment, and significant changes in the systolic time intervals were found indicating impairment of myocardial conduction and contractility. In three patients medication was discontinued due to cardiovascular side effects.

📜 SIMILAR VOLUMES

A double blind comparison of the effects
A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients
✍ D. B. Fairweather; J. S. Kerr; D. A. Harrison; C. A. Moon; I. Hindmarch 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

Sixty-six elderly depressed patients received fluoxetine 20 mg (FLU) or amitriptyline 75 mg (AMI) for 42 days in a double blind parallel group study. Each week, subjects completed a test battery which is sensitive to the residual effects of psychoactive drugs. The results show that FLU and AM1 were

Cianopramine and amitriptyline in the tr
Cianopramine and amitriptyline in the treatment of depressed patients — a placebo-controlled study
✍ L. Hormazabal; L. M. O. Omer; S. Ismail 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 330 KB

3-Cyano-imipramine (cianopramine) is a potent and selective inhibitor of serotonin uptake into synaptosomes. In a double-blind trial, 60 patients with various types of depression fulfilling the DSM-III criteria of depressive episodes were treated with either cianopramine (n=20, mean daily dose 3.3\_

Comparison of the tolerability and effic
Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice
✍ C. J. Kyle; Hans Erik Høpfner Petersen; Kerstin Fredricson Overø 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

The enhanced sensitivity of the elderly to the side effects produced by tricyclic antidepressants (TCAs), and the frequency and type of adverse events, have made the treatment of depression in this group difficult. The selective serotonin reuptake inhibitors (SSRIs) have been reported to produce sig

Experimental comparison between the effe
Experimental comparison between the effect of standardized trazodone-amitriptyline and placebo treatment in vitalized depressive patients
✍ E. Klieser; E. Lehmann 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 254 KB

We are performing a double-blind trial with inward psychiatric patients. The indication for our psychotropic or psychotherapeutic intervention is mainly severe depression (= major depressive disorders DSM III). For a 3-week trial course trazodone (400 mg daily), amitriptyline (150 mg/die) or placebo